Brief: DocMorris FY OTC Revenues Up By 6.7%
Jan 21 (Reuters) - DOCMORRIS AG DOCM.S :
* GROWS 6.7 PER CENT IN 2024 AND ACCELERATES RX GROWTH IN
THE
FOURTH QUARTER
* FY OTC REVENUES INCREASE BY 6.7 PER CENT IN 2024
* CASH POSITION OF CHF 95 MILLION AT END OF 2024
* NEW RX CUSTOMERS GREW FIVEFOLD AND RX REVENUE UP 16.6 PER
CENT
IN Q4 OF 2024
* OUTLOOK 2024 CONFIRMED
Source text: ID:nEQ4z52Yya
Further company coverage: DOCM.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on DocMorris AG
See all newsBrief: Docmorris AG Revenue And Adjusted EBITDA Guidance For 2026 Increased
Swiss stocks - Factors to watch on October 15
Brief: Docmorris Announces Final Conversion Price And Issue Size Of Its New Convertible Bonds Due 2031
Brief: Docmorris Successfully Completes The Private Placement Of Convertible Bonds Due 2031
Brief: Docmorris AG Convertible Bond Books Covered Throughout Bookbuilding Range, Says Bookrunner